Ovagen vs Prostamax — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Ovagen is a tripeptide bioregulator (Glu-Asp-Glu) developed by the St. Petersburg Institute of Bioregulation and Gerontology (Khavinson team)....
Calculate Ovagen dose →Prostamax is a tetrapeptide bioregulator (Ala-Glu-Asp-Gly) developed by the Khavinson Institute, targeted to prostate tissue support. Like other Khavinson bioregulators, it is proposed to act by entering prostate epithelial cells and modulating gene expression to normalize tissue...
Calculate Prostamax dose →| Parameter | Ovagen | Prostamax |
|---|---|---|
| Category | Organ Support | Organ Support |
| Research | Research Use (CIS) | Research Use (CIS) |
| Half-Life | - | - |
| Typical Dose | 10–30 mg/day (oral); 1–2 mg/day (SubQ) | 1–2 mg/day |
| Frequency | Daily | Daily |
| Route | Subcutaneous / Oral | Intramuscular |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.